Vivanza Biosciences Limited (BOM:530057)
India · Delayed Price · Currency is INR 2.100
-0.050 (-2.33%)
At close: Jan 20, 2026
Vivanza Biosciences Market Cap
Vivanza Biosciences has a market cap or net worth of 84 million as of January 23, 2026. Its market cap has decreased by -39.13% in one year.
Market Cap
84.00M
Enterprise Value
179.31M
Revenue
663.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.10
Market Cap Chart
Since October 23, 2012, Vivanza Biosciences's market cap has increased from 8.93M to 84.00M, an increase of 840.45%. That is a compound annual growth rate of 18.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 84.00M | -4.55% |
| Dec 31, 2025 | 88.00M | -35.67% |
| Dec 31, 2024 | 136.80M | -68.25% |
| Dec 29, 2023 | 430.80M | -30.96% |
| Dec 23, 2022 | 624.00M | -12.92% |
| Dec 27, 2021 | 716.60M | 59.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunrest Lifescience | 128.95M |
| Norris Medicines | 128.71M |
| Cian Healthcare | 125.23M |
| Colinz Laboratories | 125.20M |
| Ortin Global | 111.32M |
| Beryl Drugs | 111.12M |
| Shamrock Industrial Company | 105.25M |
| Unjha Formulations | 93.33M |